RxDoctor Payments Data

Jennifer Tabor-Curtis, APRN

Family · Mount Sterling, KYNPI 1982856472

Payments from drug & device makers

$1,007in general payments, 2019–2025

Across 59 payments — averaging $17.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$191
  • Axsome Therapeutics, Inc.$107
  • GSK$98
  • Novo Nordisk$90
  • Indivior Inc.$75
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$74
  • plus $373 from 15 others

What the payments were for

  • Food & beverage$1,007100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,007 in reported general payments places this provider in the 65th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$631
Medicare patients
25
Services billed
61

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin73$113,829
OzempicSemaglutide85$99,340
JanuviaSitagliptin Phosphate31$33,716
XareltoRivaroxaban30$31,205
FarxigaDapagliflozin Propanediol16$22,444
Aimovig AutoinjectorErenumab-Aooe11$8,070
ArexvyRsvpref3 Antigen/As01e/Pf18$4,893
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$3,235
Bupropion XlBupropion Hcl21$3,180
Ventolin HfaAlbuterol Sulfate21$2,384
Celecoxib48$2,319
Omeprazole139$1,873
Gabapentin153$1,785
Atorvastatin Calcium227$1,760
Duloxetine Hcl55$1,739

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$90$99,34085 claims
MerckJanuvia$58$33,71631 claims
Johnson & JohnsonXarelto$20$31,20530 claims
AstraZenecaFarxiga$21$22,44416 claims
GSKArexvy$98$4,89318 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,374 family providers in Kentucky.

Other family in Mount Sterling

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →